News releases
Showing 11 - 20 of 26 results
July 30, 2024
The report points to expanding indications of previously approved medications, such as semaglutide, as partial cause for the projected increase. It also urges providers to prepare for an increased nu... read more
June 26, 2024
The agreement includes access to Vizient’s industry-leading contract portfolio of medical devices, supplies and pharmaceuticals as well as analytics-enabled solutions to drive operational and clinica... read more
June 26, 2024
Sg2, a Vizient, Inc. company, released its 2024 Impact of Change®, projecting continued constraints on patient access to emergency department (ED) and inpatient (IP) care... read more
June 21, 2024
The agreement was effective in the last quarter of 2023 and reflects Vizient’s continued commitment to supporting providers in high-value care... read more
May 15, 2024
While the prevalence of behavioral health conditions was roughly the same in both groups, treatment and emergency department visits among patients in each group varied... read more
March 25, 2024
The agreement includes a suite of Vizient spend management tools and access to operational and clinical analytics... read more
August 29, 2023
The report, which utilizes data from Medicare’s Qualified Entity Program, explores outcomes through the lens of high social need communities, evaluating the cost and quality of care provided to patie... read more
August 23, 2023
A Vizient white paper demonstrates how the lack of information about medication access across the supply chain is exacerbating the shortage of seven oncology drugs used to treat a multitude of cancer... read more
January 26, 2023
Vizient, Inc. released its Winter 2023 Pharmacy Market Outlook, forecasting a 3.78% overall drug price inflation rate for the calendar year beginning, July 1, 2023... read more
December 1, 2022
Vizient released its latest Medical Device Tech Watch, highlighting data to help reduce readmission rates in heart failure patients and providing a survey of intraoperative imaging modalities. In add... read more